Top compounds associated with response to C18orf25


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.13 3e-05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.13 9e-05
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.12 0.0002
mRNA prima-1 CTRPv2 pan-cancer AAC 0.11 0.0003
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.12 0.0003
mRNA PX-12 CTRPv2 pan-cancer AAC 0.1 0.0003
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.0005
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
Download CSV